Viromed Medical AG

€4.38As of Sun 8 Nov 2026, 12:00 UTC
XETRA:VMEHealthcare
Country Germany
PE (Fwd) •••
TSR 2Y CAGR 44.43%
Div yield —
ROE 4.27%
Medical Devices
Beta (5Y) 1.74
PE TTM 272.1
TSR TTM 31.93%
Mkt cap €93.08M
ROIC (14.40%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€5.26
20.19%
233.11%
Hold 4|0|3|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.06
0.05
0.05
0.06
9.40%
(0.88%)
(1.88%)
10.73%
Revenue€M
9.195
9.598
9.393
9.114
11.60%
13.34%
6.39%
(0.57%)
Peers (US$104.5M)
Cap (US$)
PE
341.2M
—
22.02M
—
106.0M
8.077x
Capital
TTM
5Y
10Y
Leveragex
1.226
0.047
0.041
EBIT/Intx
2.623
1.214
0.945
Own earn%
(40.89)
39.04
53.68
Sh yield%
29.22
25.99
31.36
Owners
Insiders/Inst%
0.13
86.39
Short interest%
1.76
SBC / revenue%
5.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
24–32
$1 testx
—
Incr. ROIC%
32